Скачать или смотреть What are the 2023 Top Advances in Immunotherapy for Endometrial Cancer Research?

Dr. Susana Banerjee and Dr. Shira Peleg Hasson provide an overview of their commentary, “Top advances of the year: Immunotherapy in endometrial cancer,” published in CANCER, an international, interdisciplinary journal of the American Cancer Society.

They summarize data from recent phase 3 trials evaluating the addition of immune checkpoint inhibitors to chemotherapy in the first-line treatment of advanced and recurrent endometrial cancer. The discussion addresses clinical outcomes, particularly in patients with mismatch repair–deficient tumors, and outlines current questions surrounding patient selection and the role of molecular characterization.

Read the full article in CANCER: https://acsjournals.onlinelibrary.wil...

Explore more Top Advances of the Year series articles here: https://acsjournals.onlinelibrary.wil...

Follow CANCER on social media:
  / journalcancer  
  / acsjournalcancer  
  / acs-journals  

#EndometrialCancer #Immunotherapy #GynecologicOncology #CancerResearch #Oncology #PrecisionMedicine #CancerTreatment #AcademicMedicine